Reuters logo
BRIEF-Xbrane confirms order of Spherotide to value of SEK 8.5 million
September 11, 2017 / 7:00 AM / 16 days ago

BRIEF-Xbrane confirms order of Spherotide to value of SEK 8.5 million

Sept 11 (Reuters) - XBRANE BIOPHARMA AB:

* REG-XBRANE CONFIRMS ORDER OF SPHEROTIDE TO VALUE OF SEK 8.5 MILLION AND MORE THAN 10,000 DOSES SOLD

* CONFIRMS ADDITIONAL ORDER OF SPHEROTIDE FROM POOYESH DAROU TO A VALUE OF SEK 8.5 MILLION TO BE DELIVERED IN Q4 2017​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below